Crescent Biopharma (C68.F) Q3 2025 Earnings

31JulConfirmed
Q2 2025
Q3 2025
-4.47
-3.47
-2.46
-1.46

Details

Expected EPS
-1.45975654
Actual EPS
-4.316708
Surprise EPS
-2.86
Surprise Percent
+195.71%

Description

Crescent Biopharma (C68.F) has reported earnings of -4.316708 per share for Q3 2025.

0 Comments

Share your thoughts